International stem cell tourism and the need for effective regulation: Part II: Developing sound oversight measures and effective patient support

Kennedy Institute of Ethics Journal 20 (3):207-230 (2010)
  Copy   BIBTEX

Abstract

Clinics and hospitals around the globe are offering stem cell treatments to persons with serious conditions for whom no effective therapies are available in their home countries. Many of these treatments, which are touted as cures for such conditions as Parkinson's and Alzheimer's Diseases, multiple sclerosis, and spinal cord injuries, have not gone through clinical trials that establish their safety and efficacy. Indeed, it is unclear whether some of them even utilize stem cells. State regulation of these therapies tends to be weak or nonexistent in some of the countries in which they are offered. This puts those who believe they must travel abroad for stem cell treatments at risk of injury from procedures that ..

Other Versions

No versions found

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 101,225

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

Stem Cell Tourism: Addressing the Challenge of Regulatory Cosmopolitanism.Patrick Foong - 2018 - Eubios Journal of Asian and International Bioethics 28 (4):118-126.
Ownership issues in autologous stem cell therapies.Patrick Foong Chee Kuen - 2019 - Eubios Journal of Asian and International Bioethics 29 (6):186-190.

Analytics

Added to PP
2010-10-28

Downloads
190 (#128,817)

6 months
9 (#482,469)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references